Tensive was born from a shared vision to bring together advanced biomaterials science and real clinical need. What began as a research effort to create new scaffolds for connective tissue regeneration soon evolved into a focused mission: developing bioresorbable implants capable of restoring the natural architecture of soft tissues. The founders, Irini Gerges, Margherita Tamplenizza, Federico Martello and Alessandro Tocchio, combined their expertise in chemistry, biology, biomaterials and engineering to build a platform designed to make breast reconstruction safer, more natural, and more accessible for patients worldwide. By assembling the biomaterial they had developed as a scaffold in a memory foam that is 97% empty and highly compressible, they were able to develop a device designed to allow, for the first time, the regeneration of natural breast tissue through a single, one-step procedure that is minimally invasive. Today, Tensive is working toward first regulatory approvals of its devices in 2027 in the U.S. and the EU.